SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-056413
Filing Date
2021-11-03
Accepted
2021-11-03 14:00:12
Documents
15
Period of Report
2021-11-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea149890-8k_inmedpharma.htm   iXBRL 8-K 28982
2 NEWS RELEASE, DATED NOVEMBER 3, 2021 ea149890ex99-1_inmed.htm EX-99.1 14581
7 GRAPHIC ex99-1_001.jpg GRAPHIC 18443
  Complete submission text file 0001213900-21-056413.txt   273357

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20211103.xsd EX-101.SCH 3031
4 XBRL DEFINITION FILE inm-20211103_def.xml EX-101.DEF 26195
5 XBRL LABEL FILE inm-20211103_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE inm-20211103_pre.xml EX-101.PRE 22364
8 EXTRACTED XBRL INSTANCE DOCUMENT ea149890-8k_inmedpharma_htm.xml XML 3612
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 211374760
SIC: 2834 Pharmaceutical Preparations